<DOC>
	<DOCNO>NCT02509858</DOCNO>
	<brief_summary>We investigate effect administration small dos thyroxine healthy human patient type 2 diabetes postprandial forearm muscle glucose uptake , insulin sensitivity index , lipid metabolism , vitro glucose uptake GLUT4 recruitment plasma membrane monocyte .</brief_summary>
	<brief_title>The Effect Administration Small Doses Thyroxine Glucose Lipid Metabolism , Type 2 Diabetes Mellitus .</brief_title>
	<detailed_description>The present open-labeled , randomize placebo-controlled study undertaken euthyroid type 2 diabetic patient healthy human , examine effect administration small dos thyroxine within euthyroid range , muscle glucose disposal , postprandial insulin sensitivity , lipid metabolism , vitro glucose uptake GLUT4 recruitment plasma membrane monocytes.This investigate arteriovenous-difference technique consumption mixed meal vitro study glucose analogue ( 6-NBDG ) uptake peripheral monocyte . Subjects Methods : Eleven euthyroid , treatment naive , type-2 diabetic patient micronodular texture thyroid gland eleven healthy euthyroid subject , study administration 50 μg thyroxine daily 2 month . In parallel , placebo group also study . Eleven euthyroid treatment-naïve subject type 2 diabetes micronodular texture thyroid gland , match age , sex , BMI , basal thyroid function , study administration placebo , daily 2 month . Experimental protocol : All subject admit hospital 0700 h overnight fast radial artery ( A ) forearm deep vein ( V ) catheterize . A meal ( 730kcal , 50 % carbohydrate , 38 % starch , 40 % fat , 10 % protein ) give least 1 h catheter insertion consume within 20 min . Blood sample draw site meal ( -30 0 min ) 30- 60-min interval 300 min thereafter measurement thyroid hormone , glucose , total cholesterol , LDL Cholesterol , HDL Cholesterol , triglyceride , Apolipoprotein A1 , Apolipoprotein BII Lp ( ) .Forearm blood flow measure strain-gauge plethysmography . After first meal tolerance test , treatment 50μg thyroxine placebo , daily , initiated 2-month period . Then second identical test repeat . Special care take order avoid induction subclinical hyperthyroidism , suppression TSH 0.27 μU/ml , recently show latter also insulin-resistant condition .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Healthy treatment naive type 2 diabetes euthyroid subject , micronodular texture thyroid gland . Recreationally active With stable body weight diet last two month . Any systemic disease ( besides glucose abnormality ) Any medication therapy Diabetic complication</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>Diabetes mellitus , thyroxine</keyword>
</DOC>